162 related articles for article (PubMed ID: 35167190)
21. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis.
McWilliams RR; Maisonneuve P; Bamlet WR; Petersen GM; Li D; Risch HA; Yu H; Fontham ET; Luckett B; Bosetti C; Negri E; La Vecchia C; Talamini R; Bueno de Mesquita HB; Bracci P; Gallinger S; Neale RE; Lowenfels AB
Pancreas; 2016 Feb; 45(2):311-6. PubMed ID: 26646264
[TBL] [Abstract][Full Text] [Related]
22. Early detection of pancreatic cancer following the diagnosis of chronic pancreatitis.
Talamini G; Bassi C; Falconi M; Sartori N; Pasetto M; Salvia R; Di Francesco V; Frulloni L; Vaona B; Bovo P; Pederzoli P; Cavallini G
Digestion; 1999; 60(6):554-61. PubMed ID: 10545726
[TBL] [Abstract][Full Text] [Related]
23. Diabetes and pancreatic cancer.
Cui Y; Andersen DK
Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
[TBL] [Abstract][Full Text] [Related]
24. The association between diabetes mellitus of different durations and risk of pancreatic cancer: an Australian national data-linkage study in women.
Ali S; Na R; Tuesley K; Spilsbury K; Stewart LM; Coory M; Webb PM; Donovan P; Pearson SA; Jordan SJ; Neale RE
Cancer Epidemiol; 2022 Dec; 81():102266. PubMed ID: 36240705
[TBL] [Abstract][Full Text] [Related]
25. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis.
Ma J; Wang J; Ge L; Long B; Zhang J
Acta Diabetol; 2019 Oct; 56(10):1103-1111. PubMed ID: 31069497
[TBL] [Abstract][Full Text] [Related]
26. Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer?
Chia CL; Lee AY; Shelat VG; Ahmed S; Junnarkar SP; Woon WW; Low JK
Hepatobiliary Surg Nutr; 2016 Feb; 5(1):38-42. PubMed ID: 26904555
[TBL] [Abstract][Full Text] [Related]
27. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy.
Bonelli L; Aste H; Bovo P; Cavallini G; Felder M; Gusmaroli R; Morandini E; Ravelli P; Briglia R; Lombardo L; De Micheli A; Pugliese V
Pancreas; 2003 Aug; 27(2):143-9. PubMed ID: 12883263
[TBL] [Abstract][Full Text] [Related]
28. Diabetes, Weight Change, and Pancreatic Cancer Risk.
Yuan C; Babic A; Khalaf N; Nowak JA; Brais LK; Rubinson DA; Ng K; Aguirre AJ; Pandharipande PV; Fuchs CS; Giovannucci EL; Stampfer MJ; Rosenthal MH; Sander C; Kraft P; Wolpin BM
JAMA Oncol; 2020 Oct; 6(10):e202948. PubMed ID: 32789511
[TBL] [Abstract][Full Text] [Related]
29. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis.
Song S; Wang B; Zhang X; Hao L; Hu X; Li Z; Sun S
PLoS One; 2015; 10(7):e0134321. PubMed ID: 26222906
[TBL] [Abstract][Full Text] [Related]
31. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
Li D; Morris JS; Liu J; Hassan MM; Day RS; Bondy ML; Abbruzzese JL
JAMA; 2009 Jun; 301(24):2553-62. PubMed ID: 19549972
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus.
Nagpal SJS; Kandlakunta H; Her T; Sharma A; Sannapaneni S; Smyrk TC; Velamala P; Garg SK; Rakshit K; Majumder S; Chari S; Matveyenko A
Pancreatology; 2020 Jul; 20(5):929-935. PubMed ID: 32620407
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for pancreatic cancer in orientals.
Lee CT; Chang FY; Lee SD
J Gastroenterol Hepatol; 1996 May; 11(5):491-5. PubMed ID: 8743923
[TBL] [Abstract][Full Text] [Related]
34. Impact on prognosis of early weight loss during palliative chemotherapy in patients diagnosed with advanced pancreatic cancer.
Carnie L; Abraham M; McNamara MG; Hubner RA; Valle JW; Lamarca A
Pancreatology; 2020 Dec; 20(8):1682-1688. PubMed ID: 33046391
[TBL] [Abstract][Full Text] [Related]
35. Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugs.
Frič P; Škrha J; Šedo A; Bušek P; Kmochová K; Laclav M; Solař S; Bunganič B; Zavoral M
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):e19-25. PubMed ID: 27120389
[TBL] [Abstract][Full Text] [Related]
36. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
He XY; Li JF; Yao WY; Yuan YZ
Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
[TBL] [Abstract][Full Text] [Related]
37. Relationship between pancreatic cancer-associated diabetes and cachexia.
Liao WC; Chen PR; Huang CC; Chang YT; Huang BS; Chang CC; Wu MS; Chow LP
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):899-908. PubMed ID: 32100478
[TBL] [Abstract][Full Text] [Related]
38. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.
Egawa N; Lin Y; Tabata T; Kuruma S; Hara S; Kubota K; Kamisawa T
World J Gastroenterol; 2013 Apr; 19(16):2537-42. PubMed ID: 23674856
[TBL] [Abstract][Full Text] [Related]
39. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan.
Liao KF; Lai SW; Li CI; Chen WC
J Gastroenterol Hepatol; 2012 Apr; 27(4):709-13. PubMed ID: 21929650
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic carcinoma: differences between patients with or without diabetes mellitus.
Girelli CM; Reguzzoni G; Limido E; Savastano A; Rocca F
Recenti Prog Med; 1995 Apr; 86(4):143-6. PubMed ID: 7617956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
